SPRING CRAMER: Open Payments
NPI 1902030596 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,817 in 113 payments from 19 companies in 2025. Trend: 2023 $1,679 · 2024 $2,063 · 2025 $1,817
Food & beverage: $1,817
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $251 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $200 |
| Lilly USA, LLC | 12 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $159 |
| Abbott Laboratories | 9 | $159 |
| ABBVIE INC. | 18 | $153 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| PFIZER INC. | 9 | $136 |
| Phathom Pharmaceuticals, Inc. | 7 | $98 |
| Lundbeck LLC | 4 | $80 |
Products named: JARDIANCE, CAPLYTA, Rybelsus, BREZTRI, FREESTYLE LIBRE 3, NURTEC ODT, MOUNJARO, REXULTI.
Industry payments across FL — which companies pay providers there.
